When.com Web Search

  1. Ads

    related to: doctor guidelines for prescribing phentermine

Search results

  1. Results From The WOW.Com Content Network
  2. Phentermine - Wikipedia

    en.wikipedia.org/wiki/Phentermine

    Phentermine is an norepinephrine and dopamine releasing agent (NDRA) and produces stimulant, rewarding, and appetite suppressant effects. [8] [9] [10] Chemically, it is a substituted amphetamine. [11] Phentermine was approved for medical use in the United States in 1959. [3] It is available as a generic medication. [3]

  3. Phentermine/topiramate - Wikipedia

    en.wikipedia.org/wiki/Phentermine/topiramate

    Phentermine and topiramate was developed by Vivus, a California pharmaceutical company. In December 2009, Vivus, Inc. submitted a new drug application (NDA) to the FDA and on 1 March 2010, Vivus, Inc. announced that the FDA accepted the NDA for review.

  4. Medication package insert - Wikipedia

    en.wikipedia.org/wiki/Medication_package_insert

    For prescription medications, the insert is technical, providing information for medical professionals about how to prescribe the drug. Package inserts for prescription drugs often include a separate document called a "patient package insert" with information written in plain language intended for the end-user —the person who will take the ...

  5. CDC's new opioid guidelines are too little, too late for ...

    www.aol.com/news/cdcs-opioid-guidelines-too...

    The 2016 guidelines for prescribing opioids to people with chronic pain filled a vacuum for state officials searching for solutions to the overdose crisis, said Dr. Pooja Lagisetty, an assistant ...

  6. Abbrev. [1]Meaning [1] Latin (or Neo-Latin) origin [1]; a.c. before meals: ante cibum a.d., ad, AD right ear auris dextra a.m., am, AM morning: ante meridiem: nocte ...

  7. Norepinephrine–dopamine reuptake inhibitor - Wikipedia

    en.wikipedia.org/wiki/Norepinephrine–dopamine...

    The skeletal structure of norepinephrine The skeletal structure of dopamine. A norepinephrine–dopamine reuptake inhibitor (NDRI) is a drug used for the treatment of clinical depression, attention deficit hyperactivity disorder (ADHD), narcolepsy, and the management of Parkinson's disease.